NeutriSci International Inc (NU) - Total Assets

Latest as of September 2023: CA$127.83K CAD ≈ $92.47K USD

Based on the latest financial reports, NeutriSci International Inc (NU) holds total assets worth CA$127.83K CAD (≈ $92.47K USD) as of September 2023. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

NeutriSci International Inc - Total Assets Trend (2001–2022)

This chart illustrates how NeutriSci International Inc's total assets have evolved over time, based on quarterly financial data. Also see NU market cap for the company's overall valuation and market capitalisation.

NeutriSci International Inc - Asset Composition Analysis

Current Asset Composition (December 2022)

NeutriSci International Inc's total assets of CA$127.83K consist of 60.1% current assets and 39.9% non-current assets. Review NeutriSci International Inc (NU) total liabilities to assess the company's total debt and financial obligations.

Asset Category	Amount (CAD)	% of Total Assets
Cash & Equivalents	CA$0.00	52.9%
Accounts Receivable	CA$8.81K	2.7%
Inventory	CA$15.00K	4.5%
Property, Plant & Equipment	CA$132.34K	39.9%
Intangible Assets	CA$0.00	0.0%
Goodwill	CA$0.00	0.0%

Asset Composition Trend (2001–2022)

This chart illustrates how NeutriSci International Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See today's stock price for NeutriSci International Inc for real-time trading data and today's change.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: NeutriSci International Inc's current assets represent 60.1% of total assets in 2022, a decrease from 100.0% in 2001.
Cash Position: Cash and equivalents constituted 52.9% of total assets in 2022, down from 99.5% in 2001.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2001.
Asset Diversification: The largest asset category is property, plant & equipment at 39.9% of total assets.

NeutriSci International Inc Competitors by Total Assets

Key competitors of NeutriSci International Inc based on total assets are shown below.

Company	Country	Total Assets
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Germany	€1.60 Trillion
GALDERMA GROUP AG NYSE:GALDY	USA	$13.39 Billion
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	USA	$15.42 Trillion
Beijing Tongrentang Co Ltd SHG:600085	China	CN¥31.82 Billion
Takeda Pharmaceutical Company Limited F:TKDA	Germany	€15.41 Trillion
Changchun High & New Technology Industries Group Inc SHE:000661	China	CN¥30.77 Billion
Neuland Laboratories Limited NSE:NEULANDLAB	India	Rs29.30 Billion
China Resources Double-Crane Pharmaceutical Co Ltd SHG:600062	China	CN¥17.01 Billion

NeutriSci International Inc - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	0.02	0.16	1.91
Quick Ratio	0.01	0.02	1.48
Cash Ratio	0.00	0.00	0.00
Working Capital	CA$-911.80K	CA$-677.67K	CA$251.41K

NeutriSci International Inc - Advanced Valuation Insights

This section examines the relationship between NeutriSci International Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	20.28
Latest Market Cap to Assets Ratio	2.69
Asset Growth Rate (YoY)	-59.6%
Total Assets	CA$331.43K
Market Capitalization	$892.12K USD

Valuation Analysis

Premium Asset Valuation: The market values NeutriSci International Inc's assets at a significant premium (2.69x), suggesting investors see substantial growth potential or unique competitive advantages.

Significant Asset Reduction: NeutriSci International Inc's assets decreased by 59.6% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for NeutriSci International Inc (2001–2022)

The table below shows the annual total assets of NeutriSci International Inc from 2001 to 2022.

Year	Total Assets	Change
2022-12-31	CA$331.43K ≈ $239.75K	-59.56%
2021-12-31	CA$819.51K ≈ $592.82K	+55.13%
2020-12-31	CA$528.28K ≈ $382.15K	+4.65%
2019-12-31	CA$504.81K ≈ $365.18K	-8.80%
2018-12-31	CA$553.55K ≈ $400.43K	-7.91%
2017-12-31	CA$601.12K ≈ $434.84K	-47.27%
2016-12-31	CA$1.14 Million ≈ $824.62K	-33.18%
2015-12-31	CA$1.71 Million ≈ $1.23 Million	-33.35%
2014-12-31	CA$2.56 Million ≈ $1.85 Million	-60.74%
2014-09-30	CA$6.52 Million ≈ $4.72 Million	+1180.85%
2012-12-31	CA$508.96K ≈ $368.18K	+298.53%
2011-12-31	CA$127.71K ≈ $92.38K	+39.96%
2010-12-31	CA$91.25K ≈ $66.01K	-45.82%
2009-12-31	CA$168.42K ≈ $121.83K	-7.88%
2008-12-31	CA$182.84K ≈ $132.26K	-13.46%
2007-12-31	CA$211.28K ≈ $152.84K	-60.19%
2006-12-31	CA$530.74K ≈ $383.93K	+49.66%
2005-12-31	CA$354.63K ≈ $256.54K	-9.55%
2004-12-31	CA$392.07K ≈ $283.62K	-70.10%
2003-12-31	CA$1.31 Million ≈ $948.54K	+664.22%
2002-12-31	CA$171.58K ≈ $124.12K	-50.35%
2001-12-31	CA$345.55K ≈ $249.97K	--

About NeutriSci International Inc

V:NU Canada Drug Manufacturers - Specialty & Generic

Market Cap

$1.83 Billion

CA$2.53 Billion CAD

Market Cap Rank

#30770 Global

#1597 in Canada

Share Price

CA$14.19

Change (1 day)

-5.53%

52-Week Range

CA$11.60 - CA$18.76

All Time High

CA$18.76